Intengo enhle i-99% ye-Orlistat/Orlistat powder yezinga lemithi i-CAS 96829-58-2

Izingeniso:
I-Orlistat umuthi owenzelwe ukwelapha ukukhuluphala. Umsebenzi wayo oyinhloko ukuvimbela ukumuncwa kwamafutha ekudleni kwabantu ngokusebenza njengomvimbeli we-lipase, ngaleyo ndlela kuncishiswe ukudla okunama-calories. Ihloselwe ukusetshenziswa kanye nokudla okunama-calories ancishisiwe okuqondiswa umhlinzeki wezempilo.

I-Orlistat iyi-derivative egcwele ye-lipstatin, i-inhibitor yemvelo enamandla yama-lipases e-pancreatic ahlukaniswe ne-bacterium Streptomyces toxytricini. Kodwa-ke, ngenxa yobulula bayo kanye nokuqina kwayo, i-orlistat yakhethwa kune-lipstatin ukuze ithuthukiswe njengomuthi wokulwa nokukhuluphala.

Ukusebenza kahle kwe-orlistat ekukhuthazeni ukwehlisa isisindo kuqinisekile kodwa kuncane. Idatha ehlanganisiwe evela ezivivinyweni zemitholampilo iphakamisa ukuthi abantu abanikezwe i-orlistat ngaphezu kokushintsha indlela yokuphila, njengokudla nokuzivocavoca, balahlekelwa cishe amakhilogremu angu-2-3 (4.4-6.6 lb) ngaphezu kwalabo abangawuthathi umuthi phakathi nonyaka. I-Orlistat iphinde yehlise umfutho wegazi ngokulinganisela futhi ibonakala ivimbela ukuqala kwesifo sikashukela sohlobo 2, kungaba ngenxa yokulahlekelwa isisindo ngokwaso noma eminye imiphumela. Esivivinyweni esikhulu esilawulwa ngokungahleliwe, i-orlistat yatholakala ukuthi yehlisa izinga lesifo sikashukela cishe ngo-40% kubantu abakhuluphele.

Izicelo:
I-Orlistat isetshenziswa nokudla okunama-calorie aphansi ukukusiza unciphise isisindo futhi ugcine isisindo sakho ngemva kokwehlisa isisindo. I-Orlistat isesigabeni semithi ebizwa ngokuthi i-lipase inhibitors. Isebenza emathunjini akho, lapho ivimba khona amanye amafutha owadlayo ukuthi angamuncwa futhi agaywe. La mafutha angagaywanga abe esesuswa ekunyakazeni kwakho kwamathumbu.

Ukupakisha:
25kg/ibhokisi